417 related articles for article (PubMed ID: 21908556)
1. Breast cancer subtype-specific interactions with the microenvironment dictate mechanisms of invasion.
Dang TT; Prechtl AM; Pearson GW
Cancer Res; 2011 Nov; 71(21):6857-66. PubMed ID: 21908556
[TBL] [Abstract][Full Text] [Related]
2. ΔNp63α Promotes Breast Cancer Cell Motility through the Selective Activation of Components of the Epithelial-to-Mesenchymal Transition Program.
Dang TT; Esparza MA; Maine EA; Westcott JM; Pearson GW
Cancer Res; 2015 Sep; 75(18):3925-35. PubMed ID: 26292362
[TBL] [Abstract][Full Text] [Related]
3. Establishment of a 3D co-culture model to investigate the role of primary fibroblasts in ductal carcinoma in situ of the breast.
Sourouni M; Opitz C; Radke I; Kiesel L; Tio J; Götte M; von Wahlde MK
Cancer Rep (Hoboken); 2023 Apr; 6(4):e1771. PubMed ID: 36534078
[TBL] [Abstract][Full Text] [Related]
4. Role of HGF in epithelial-stromal cell interactions during progression from benign breast disease to ductal carcinoma in situ.
Casbas-Hernandez P; D'Arcy M; Roman-Perez E; Brauer HA; McNaughton K; Miller SM; Chhetri RK; Oldenburg AL; Fleming JM; Amos KD; Makowski L; Troester MA
Breast Cancer Res; 2013; 15(5):R82. PubMed ID: 24025166
[TBL] [Abstract][Full Text] [Related]
5. MAME models for 4D live-cell imaging of tumor: microenvironment interactions that impact malignant progression.
Sameni M; Anbalagan A; Olive MB; Moin K; Mattingly RR; Sloane BF
J Vis Exp; 2012 Feb; (60):. PubMed ID: 22371028
[TBL] [Abstract][Full Text] [Related]
6. An Organotypic Mammary Duct Model Capturing Matrix Mechanics-Dependent Ductal Carcinoma
Kulwatno J; Gong X; DeVaux R; Herschkowitz JI; Mills KL
Tissue Eng Part A; 2021 Apr; 27(7-8):454-466. PubMed ID: 33397202
[TBL] [Abstract][Full Text] [Related]
7. FAP-overexpressing fibroblasts produce an extracellular matrix that enhances invasive velocity and directionality of pancreatic cancer cells.
Lee HO; Mullins SR; Franco-Barraza J; Valianou M; Cukierman E; Cheng JD
BMC Cancer; 2011 Jun; 11():245. PubMed ID: 21668992
[TBL] [Abstract][Full Text] [Related]
8. Expression profiling of in vivo ductal carcinoma in situ progression models identified B cell lymphoma-9 as a molecular driver of breast cancer invasion.
Elsarraj HS; Hong Y; Valdez KE; Michaels W; Hook M; Smith WP; Chien J; Herschkowitz JI; Troester MA; Beck M; Inciardi M; Gatewood J; May L; Cusick T; McGinness M; Ricci L; Fan F; Tawfik O; Marks JR; Knapp JR; Yeh HW; Thomas P; Carrasco DR; Fields TA; Godwin AK; Behbod F
Breast Cancer Res; 2015 Sep; 17():128. PubMed ID: 26384318
[TBL] [Abstract][Full Text] [Related]
9. Fibroblast hepatocyte growth factor promotes invasion of human mammary ductal carcinoma in situ.
Jedeszko C; Victor BC; Podgorski I; Sloane BF
Cancer Res; 2009 Dec; 69(23):9148-55. PubMed ID: 19920187
[TBL] [Abstract][Full Text] [Related]
10. Microfluidic model of ductal carcinoma in situ with 3D, organotypic structure.
Bischel LL; Beebe DJ; Sung KE
BMC Cancer; 2015 Jan; 15():12. PubMed ID: 25605670
[TBL] [Abstract][Full Text] [Related]
11. Elevated NRAS expression during DCIS is a potential driver for progression to basal-like properties and local invasiveness.
Zheng ZY; Elsarraj H; Lei JT; Hong Y; Anurag M; Feng L; Kennedy H; Shen Y; Lo F; Zhao Z; Zhang B; Zhang XH; Tawfik OW; Behbod F; Chang EC
Breast Cancer Res; 2022 Oct; 24(1):68. PubMed ID: 36258226
[TBL] [Abstract][Full Text] [Related]
12. Chemokine Signaling Facilitates Early-Stage Breast Cancer Survival and Invasion through Fibroblast-Dependent Mechanisms.
Brummer G; Acevedo DS; Hu Q; Portsche M; Fang WB; Yao M; Zinda B; Myers M; Alvarez N; Fields P; Hong Y; Behbod F; Cheng N
Mol Cancer Res; 2018 Feb; 16(2):296-308. PubMed ID: 29133591
[TBL] [Abstract][Full Text] [Related]
13. Myoepithelial cell-specific expression of stefin A as a suppressor of early breast cancer invasion.
Duivenvoorden HM; Rautela J; Edgington-Mitchell LE; Spurling A; Greening DW; Nowell CJ; Molloy TJ; Robbins E; Brockwell NK; Lee CS; Chen M; Holliday A; Selinger CI; Hu M; Britt KL; Stroud DA; Bogyo M; Möller A; Polyak K; Sloane BF; O'Toole SA; Parker BS
J Pathol; 2017 Dec; 243(4):496-509. PubMed ID: 29086922
[TBL] [Abstract][Full Text] [Related]
14. The transcriptional regulator TBX3 promotes progression from non-invasive to invasive breast cancer.
Krstic M; Macmillan CD; Leong HS; Clifford AG; Souter LH; Dales DW; Postenka CO; Chambers AF; Tuck AB
BMC Cancer; 2016 Aug; 16(1):671. PubMed ID: 27553211
[TBL] [Abstract][Full Text] [Related]
15. Paracrine recruitment and activation of fibroblasts by c-Myc expressing breast epithelial cells through the IGFs/IGF-1R axis.
De Vincenzo A; Belli S; Franco P; Telesca M; Iaccarino I; Botti G; Carriero MV; Ranson M; Stoppelli MP
Int J Cancer; 2019 Nov; 145(10):2827-2839. PubMed ID: 31381136
[TBL] [Abstract][Full Text] [Related]
16. SMARCE1 is required for the invasive progression of in situ cancers.
Sokol ES; Feng YX; Jin DX; Tizabi MD; Miller DH; Cohen MA; Sanduja S; Reinhardt F; Pandey J; Superville DA; Jaenisch R; Gupta PB
Proc Natl Acad Sci U S A; 2017 Apr; 114(16):4153-4158. PubMed ID: 28377514
[TBL] [Abstract][Full Text] [Related]
17. Il-6 signaling between ductal carcinoma in situ cells and carcinoma-associated fibroblasts mediates tumor cell growth and migration.
Osuala KO; Sameni M; Shah S; Aggarwal N; Simonait ML; Franco OE; Hong Y; Hayward SW; Behbod F; Mattingly RR; Sloane BF
BMC Cancer; 2015 Aug; 15():584. PubMed ID: 26268945
[TBL] [Abstract][Full Text] [Related]
18. Novel multicellular organotypic models of normal and malignant breast: tools for dissecting the role of the microenvironment in breast cancer progression.
Holliday DL; Brouilette KT; Markert A; Gordon LA; Jones JL
Breast Cancer Res; 2009; 11(1):R3. PubMed ID: 19152687
[TBL] [Abstract][Full Text] [Related]
19. The angiotensin receptor blocker, Losartan, inhibits mammary tumor development and progression to invasive carcinoma.
Coulson R; Liew SH; Connelly AA; Yee NS; Deb S; Kumar B; Vargas AC; O'Toole SA; Parslow AC; Poh A; Putoczki T; Morrow RJ; Alorro M; Lazarus KA; Yeap EFW; Walton KL; Harrison CA; Hannan NJ; George AJ; Clyne CD; Ernst M; Allen AM; Chand AL
Oncotarget; 2017 Mar; 8(12):18640-18656. PubMed ID: 28416734
[TBL] [Abstract][Full Text] [Related]
20. Epithelial-mesenchymal transition increases during the progression of in situ to invasive basal-like breast cancer.
Choi Y; Lee HJ; Jang MH; Gwak JM; Lee KS; Kim EJ; Kim HJ; Lee HE; Park SY
Hum Pathol; 2013 Nov; 44(11):2581-9. PubMed ID: 24055090
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
